Results 221 to 230 of about 192,512 (365)

A 4-Week-Old Female Infant with Type 3 von Willebrand Disease Presenting with Nosebleeds and Uncontrolled Bleeding Following Surgical Frenectomy: A Clinical Case. [PDF]

Am J Case Rep
Zima A, Iwaniec T, Zdziarska J, Sacha T, Żuber Z.   +4 more
europepmc   +1 more source

Characterization of the interaction between von Willebrand factor and osteoprotegerin

Journal of Thrombosis and Haemostasis, 2007
Shirin Shahbazi, P. Lenting, C. Fribourg, Virginie Terraube, Cécile V. Denis, O. Christophe   +5 more
semanticscholar   +1 more source

What is your diagnosis? Fine‐needle aspirate from a neck lesion in a dog

Veterinary Clinical Pathology, EarlyView.
Cynthia Robveille, Marie Cuvelier
wiley   +1 more source

Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry

Annals of Neurology, Volume 97, Issue 6, Page 1205-1214, June 2025.
Objectives Intravenous thrombolysis (IVT) is contraindicated for acute ischemic stroke (AIS) patients taking direct oral anticoagulants (DOACs) within 48 hours before index stroke. Limited data exist on off‐label use of IVT for these patients. We compared the safety and outcomes of IVT in AIS patients with DOAC treatment and patients with no OAC before
Marius Matusevicius, Malin Säflund, Maurizio Balestrino, Manuel Cappellari, Delfina Ferrandi, Abdoreza Ghoreishi, André Peeters, Viiu‐Marika Rand, Manuela De Michele, Aleksandras Vilionskis, Andrea Zini, Niaz Ahmed   +11 more
wiley   +1 more source

Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis

Research and Practice in Thrombosis and Haemostasis
Background: Between 2002 and 2011, the incidence of severe primary postpartum hemorrhage (PPH) in Dutch women with von Willebrand disease (VWD) and hemophilia carriers (HCs) was 8% vs 4.5% in the general population.
Marieke Punt, Fe van Leusden, Kitty Bloemenkamp, Michiel Coppens, Mariette Driessens, Floor Heubel-Moenen, Titia Lely, Anja Mäkelburg, Laurens Nieuwenhuizen, Saskia Haitjema, Wouter van Solinge, Joline Saes, Saskia Schols, Roger Schutgens, Jeroen Eikenboom, Marieke Kruip, Karin van Galen   +16 more
doaj  

Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma. [PDF]

Hematol Rep
Julien M, Pierre L, Gérout AC, Sattler L, Feugeas O, Desprez D.   +5 more
europepmc   +1 more source

Study of von Willebrand factor, antithrombin III and protein C in patients with cerebrovascular disease.

, 1988
Akihiro Ihara, Yasuki Kobayashi, Tadao Morimoto, Yasuaki NOMA, Kazunari Oda, Ryuji Yamashita, Masakaze Nakata, Kingo Fujimura, Atsushi Kuramoto   +8 more
openalex   +2 more sources

Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma) [PDF]

, 2001
A Scheja, Anita Åkesson, Pierre Geborek, Marie Wildt, Claes B. Wollheim, Frank A. Wollheim, Ulrich M. Vischer   +6 more
openalex   +1 more source

Von Willebrand factor: Looking back and looking forward

Thrombosis and Haemostasis, 2007
Z. Ruggeri
semanticscholar   +1 more source

Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib

Clinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT We present a woman with severe refractory livedoid vasculopathy who was successfully treated with tofacitinib (5 mg twice a day). The ulcers gradually healed over a period of 2–3 months without experiencing any adverse events over a 1‐year follow‐up period.
Parvin Mansouri, Nikoo Mozafari
wiley   +1 more source